Cartilage Health: A Nutritional and Natural-Health Reference
1. Definition and Biological Overview
Cartilage is a strong, flexible connective tissue that protects joints and bones, doing everything from helping joints move smoothly to absorbing impacts. It has many functions, including resisting compressive forces, enhancing bone resilience, and providing support in bony areas where flexibility is needed.
The primary cell that makes cartilage is the chondrocyte, which resides within the lacunae. The cartilage matrix consists of fibrous tissue and various combinations of proteoglycans and glycosaminoglycans. Cartilage, once synthesized, lacks a lymphatic or blood supply, and the movement of waste and nutrition is chiefly done via diffusion to and from adjacent tissues. This avascularity is central to understanding why cartilage has limited regenerative capacity and why nutritional delivery to chondrocytes depends on joint loading and synovial fluid diffusion.
1.1 Types of Cartilage
There are three main types of cartilage: hyaline, fibrocartilage, and elastic cartilage, each serving distinct functions and displaying unique properties tailored to their specific locations in the body, such as joints, the respiratory system, and the ear.
- Hyaline cartilage: Hyaline cartilage is the most copious type of cartilage in the human body. It is pale blue-white and smooth to the touch, and is primarily composed of type II collagen and proteoglycans. It persists in human adults at the ends of bones in free-moving joints as articular cartilage, at the ends of the ribs, and in the nose, larynx, trachea, and bronchi. The surface is usually moist, but the cartilage becomes dry, thinner, and more yellow with age.
- Fibrocartilage: Fibrocartilage is the tough, very strong tissue found predominantly in the intervertebral disks and at the insertions of ligaments and tendons; it is similar to other fibrous tissues but contains cartilage ground substance and chondrocytes. Fibrocartilage aids in attaching tendons and ligaments to the bone, providing strength and stability to these critical connections in the musculoskeletal system.
- Elastic cartilage: Elastic cartilage, in addition to type II collagen fibers, also contains elastin — a protein that gives this type of cartilage a distinct characteristic — and is essential for parts of the body that need to bend and move freely.
1.2 Body Systems Involved
In the adult, cartilage is a tough but flexible tissue present in the skeletal and respiratory system and the ear, where its main function is structural support. Within the musculoskeletal system, articular (hyaline) cartilage is the primary tissue of concern in joint health discussions. Healthy articular cartilage allows joints to move and glide over each other with very little friction, but is subject to damage and injury, as well as normal wear and tear.
Beyond the musculoskeletal system, cartilage is implicated in respiratory tract architecture (tracheal and bronchial rings), auditory anatomy (ear pinnae), and spinal integrity. During spinal disk herniation, cartilage malfunction causes an asymmetric compression within the intervertebral disk, producing a herniation of its soft content that compresses nearby nerves and results in back pain.
2. How Cartilage Degeneration Presents
While osteoarthritis is a disease that affects the whole joint, one of the most affected tissues is the articular cartilage, which is thinned or completely worn away. This results in "bone against bone" grinding within the joint that leads to reduced range of movement, loss of proprioception, and pain.
As a largely nonvascular tissue, cartilage has limited capacity for self-repair, making it susceptible to various disorders, including osteoarthritis, costochondritis, and genetic conditions like achondroplasia. Cartilage damage can significantly impact mobility and quality of life, with common symptoms including joint pain and inflammation.
Osteoarthritis (OA) is the most common form of arthritis and a major cause of pain and disability in older adults. Often OA is referred to as degenerative joint disease (DJD). This is a misnomer because OA is not simply a process of wear and tear but rather abnormal remodeling of joint tissues driven by a host of inflammatory mediators within the affected joint.
It has been observed that cartilage degeneration is preceded by subchondral bone lesions, suggesting a key role of this mechanism within the pathogenesis and progression of OA, as well as the formation of ectopic bone and osteophytes. Moreover, low-grade, chronic inflammation of the synovial lining has gained a central role in the definition of OA physiopathology, and central immunological mechanisms, innate but also adaptive, are now considered crucial in driving inflammation and tissue destruction.
3. Contributing and Associated Factors
3.1 Age
Increased age is the strongest risk factor for OA; aging-related changes in cartilage may contribute to the excessive matrix remodelling response. These aging changes include the accumulation of advanced glycation end-products that make the cartilage more "brittle" and the appearance of chondrocytes with features of the senescence-associated secretory phenotype, including increased production of many cytokines, chemokines, and MMPs.
3.2 Obesity and Mechanical Loading
Risk factors for cartilage loss in osteoarthritis are related either to the adverse effects of trauma or overloading (e.g., injury and obesity) on otherwise normal cartilage or normal loading on abnormal cartilage (e.g., genetic defects and aging), both of which result in abnormal biomechanics and malalignment.
Female sex and obesity have been strongly correlated with knee OA. Knee malalignment and knee extensor muscle weakness have also been defined as moderate to strong risk factors.
3.3 Joint Injury and Trauma
Magnetic resonance imaging studies reveal a high frequency of meniscal lesions in OA joints, and meniscal damage as well as ligament damage are clear risk factors for development of OA. Pathology in the menisci and ligaments most likely contributes to the development of OA through altered biomechanics. The altered mechanical forces, factors released from subchondral bone, and in some cases inflammatory mediators released from the synovium all can contribute to the cartilage pathology in OA.
3.4 Genetics and Sex
The most common risk factors for OA include age, gender, prior joint injury, obesity, genetic predisposition, and mechanical factors, including malalignment and abnormal joint shape.
3.5 Inflammation and Synovial Cross-Talk
An inflammatory component exists in OA, marked by joint pain, swelling, and stiffness, and accompanied by synovitis and the production of inflammatory cytokines. Potential etiological factors contributing to osteoarthritis development in the ACL-deficient knee include patients' age at time of injury, time from the onset of injury, obesity, joint malalignment, concomitant presence of an acute meniscal or cartilage injury, as well as biological factors, such as increase in catabolic activity of chondrocytes, inflammatory cytokines and proteases activation. It is known that as a response to mechanical forces and consequent matrix loss, the healthy adult chondrocyte produces a series of inflammatory mediators, many of which are normally produced by macrophages in response to injury or infection.
4. Nutrients, Herbs, and Natural Ingredients
4.1 Glucosamine
Traditional/Background use: Glucosamine is a natural constituent of hyaline cartilage. Proponents of these treatments suggest that oral supplements increase the concentration of these components of cartilage in the joint and may help to preserve, or even repair, the damaged joint in OA.
Proposed mechanisms: Glucosamine has been shown to decrease inflammation by the reduction in several different inflammatory mediators, including reactive oxygen species, NF-κB activation, C-reactive protein, IL-1, IL-6, and TNF-α, while upregulating the anti-inflammatory mediators IL-2 and IL-10. Glucosamine has been shown to inhibit phospholipase A2, matrix metalloproteinases (MMPs), and aggregases, and has also been shown to increase aggrecan and collagen type II, which are components of the extracellular matrix.
Scientific evidence: Eight primary trials of at least 12 months' duration were included in a systematic NIHR review; there was evidence of statistically significant improvements in joint space loss, pain and function for glucosamine sulphate; however, the clinical importance of these differences was less clear. In two studies of glucosamine sulphate, both funded by the manufacturer, the need for knee arthroplasty was reduced from 14.5% to 6.3% at 8 years' follow-up. For other preparations of glucosamine, chondroitin and combination therapy, there was less evidence to support a clinical effect. Overall, the evidence base is heterogeneous and results vary by formulation (sulphate vs. hydrochloride), funding source, and study quality.
4.2 Chondroitin Sulfate
Background: Chondroitin is a component of cartilage that plays a role in its resistance to compression.
Proposed mechanisms: Chondroitin has been shown to reduce inflammation primarily through the reduction in NF-κB activation and in IL-1β, which is a key inflammatory marker that causes articular inflammation and cartilage damage. Chondroitin has been shown to significantly decrease collagenolytic activity and to induce proteoglycan production.
Scientific evidence: A 2025 systematic review concluded that glucosamine and chondroitin are generally effective and well-tolerated, particularly for managing osteoarthritis and joint pain, with consistent dosing strategies and favorable safety profiles across a diverse range of studies, though further research is needed. A separate preclinical systematic review found a large inconsistency among experimental protocols, but a positive cartilage response and biochemical modulation were observed in about half of the evaluated articles; additional data are needed to draw solid conclusions. The overall picture across human trials remains mixed; benefit is more consistent for symptom management than for structural modification.
4.3 Collagen: Hydrolyzed and Undenatured Type II
Background: Hyaline cartilage is primarily composed of type II collagen and proteoglycans. Supplemental collagen is available in two main forms: hydrolyzed collagen peptides (HC), which provide amino acid building blocks, and undenatured type II collagen (UC-II), which is thought to work via oral tolerance mechanisms.
Scientific evidence — hydrolyzed collagen: Collagen hydrolysate is a nutritional supplement that has been shown to exert an anabolic effect on cartilage tissue, and its administration appears beneficial in patients with osteoarthritis. A prospective, randomized, placebo-controlled, double-blind study was conducted at Penn State University, evaluating the effect of collagen hydrolysate on activity-related joint pain in athletes who had no evidence of joint disease. This was the first clinical trial of 24 weeks' duration to show improvement of joint pain in athletes treated with the dietary supplement collagen hydrolysate.
A double-blind, randomized, placebo-controlled trial observed a more significant reduction in joint stiffness and increased mobility in the hydrolyzed collagen group compared with the placebo group, which may be explained by the process through which hydrolyzed collagen is absorbed intestinally, accumulates in the cartilage, and stimulates the regeneration of chondrocytes.
Scientific evidence — combined formulations: Previous clinical studies have primarily evaluated individual collagen formulations, with most being industry-sponsored, which raises potential bias concerns. A randomized, double-blind, placebo-controlled trial assessed combined undenatured type II collagen and hydrolyzed collagen supplementation in 68 patients with knee osteoarthritis, divided into treatment and placebo groups. It is possible that the clinical benefits of collagen supplementation, particularly those related to cartilage metabolism and repair, may require longer durations to become detectable. Evidence for collagen supplementation is promising but largely preliminary and often industry-funded; well-powered independent trials are needed.
4.4 Methylsulfonylmethane (MSM)
Background and proposed mechanism: Methylsulfonylmethane (MSM) is a food ingredient present in small amounts in many foods, and its anti-inflammatory effects have been reported. Sulfur is the fourth most abundant mineral element after calcium, phosphorus, and potassium and is present in relatively large amounts in hair, nails, skin, and cartilage. Inhibition of NF-κB by MSM causes suppression of IL-1, IL-6, and TNF-α expression at the mRNA level.
Scientific evidence: A randomized, double-blind, placebo-controlled trial of oral MSM was conducted on mild pain of the knee joint in healthy Japanese participants. A total of 88 participants were enrolled and randomly assigned to MSM consumption (n=44) or placebo (n=44); both groups took their respective tablets daily for 12 weeks. The primary outcome was the total score of the Japanese Knee Osteoarthritis Measure (JKOM) at 12 weeks. The total scores at 12 weeks in the MSM and placebo groups were significantly different (p = 0.046). The effect size for methylsulfonylmethane is considered to be clinically relevant based on a review published in Current Rheumatology Reports, though confirmation in larger, independent trials is needed.
4.5 Hyaluronic Acid (Oral)
Background: Hyaluronic acid (HA) is a major component of synovial fluid and the cartilage extracellular matrix, contributing to lubrication and shock absorption. Oral HA supplementation has been studied as an alternative to intra-articular injection.
Scientific evidence: Animal and in vitro studies showed that HA significantly reduced joint swelling, increased HA content in the serum and joint synovial fluid, decreased levels of pro-inflammatory cytokines, and reduced the expression of MMPs, iNOS, and COX-2, with these protective roles attributed to immune regulation by HA. Clinical trial results indicated that oral HA significantly decreased pain, stiffness, and physical function WOMAC scores, with no significant impact on blood and urine indices, suggesting that oral HA supplementation can reduce the progression of arthritis, pain, and cartilage damage. The overall evidence for oral HA remains limited in scope; intra-articular injection has a substantially larger clinical evidence base.
4.6 Avocado-Soybean Unsaponifiables (ASU)
Background: Avocado-soybean unsaponifiables (ASUs) refer to an extract from avocado and soybean oils that may help prevent cartilage breakdown and repair it.
Scientific evidence: Individuals with primary femorotibial or hip OA of at least six months' duration were dosed with 300 mg of a 2:1 avocado:soybean unsaponifiable preparation for 3 months; indices including NSAID intake, Lequesne's index, and physician visual analog scale for pain and functional index all showed improvement at p<0.01 or better. In a double-blind study, individuals with knee OA were dosed with 300 or 600 mg of ASU for three months; all indices improved with treatment at p<0.01 or better, with NSAID intake decreasing by more than 50% in 71% of the individuals compared to 36% in those receiving placebo, and Lequesne's index dropping by 3.9 and 2.9 points in the ASU 300 and 600 mg groups respectively against 1.6 in placebo. The effect size for ASU is considered clinically relevant, though data from a small number of studies are promising but require confirmation in further well-designed clinical trials.
4.7 Boswellia serrata (Indian Frankincense)
Traditional use: Frankincense (also known as olibanum) is a fragrant resinous extract from moderate-sized deciduous trees of the genus Boswellia; four Boswellia species produce frankincense, including Boswellia sacra, B. frereana, B. serrata, and B. papyrifera. Boswellia serrata has been used for centuries in Ayurvedic medicine for inflammatory joint conditions.
Proposed mechanisms: Specifically, 3-O-Acetyl-11-keto-beta-boswellic acid (AKBA) in Boswellia serrata extract exerts anti-inflammatory effects by inhibiting 5-lipoxygenase, a primary source of pro-inflammatory leukotrienes. Both curcuminoid and boswellia formulations have been shown to counteract decreases in glycosaminoglycan levels and impede the secretion and activity of MMPs, which could potentially forestall further degradation of cartilaginous tissue.
Scientific evidence: 5-Loxin® is a novel Boswellia serrata extract enriched with 30% AKBA, which exhibits potential anti-inflammatory properties by inhibiting the 5-lipoxygenase enzyme. A 90-day, double-blind, randomized, placebo-controlled study was conducted to evaluate its efficacy and safety in OA of the knee; seventy-five OA patients received either 100 mg, 250 mg, or placebo daily for 90 days. A meta-analysis published in 2020 demonstrated that Boswellia serrata extract is both safe and effective for OA patients. A recent randomized, placebo-controlled, double-blind clinical trial in 62 participants used a standardized Boswellia serrata gum resin (300 mg) to determine its safety and efficacy for supporting cartilage health and reduction in knee OA symptoms. Oral administration of the nutraceutical resulted in prolonged symptomatic relief with reduced pain, stiffness, and swelling, and inflammatory and cartilage degeneration biomarkers were decreased. Pharmacokinetic studies have found that boswellic acids exhibit poor bioavailability when taken orally.
4.8 Curcumin (from Turmeric, Curcuma longa)
Traditional use: Turmeric root has been used in Ayurvedic and traditional Chinese medicine for centuries as an anti-inflammatory agent for joint and musculoskeletal conditions.
Proposed mechanisms: Acetyl-keto-beta-boswellic acid and curcuminoids have inhibitory effects on inflammatory NF-κB and its gene products, some of which are directly involved in osteoclastogenesis. Curcuminoids act as inhibitors to the enzyme COX-2, which is associated with inflammatory processes and pain, by blocking the action of tumor necrosis factor.
Scientific evidence: Numerous plant extracts, including curcumin, Boswellia extract, and pycnogenol, have shown effect sizes for reducing pain and functional disability larger than those observed with analgesics and products such as glucosamine and chondroitin. A systematic review and meta-analysis included 14 RCTs (N=1,215); five RCTs compared curcuminoid formulations against placebo (N=331), and four trials compared boswellia formulations against placebo (N=216). Two RCTs assessed the effectiveness of Curcuma longa extract as an adjuvant therapy with NSAIDs; one trial reported that combination treatment with Curcuma longa extract and diclofenac showed similar benefits in pain and functional outcomes to diclofenac alone. A significant limitation of curcumin research is its poor systemic bioavailability in standard forms; data from a small number of studies are promising but require confirmation in further well-designed clinical trials.
4.9 Vitamin C (Ascorbic Acid)
Role in cartilage biology: Vitamin C is an obligate cofactor for the hydroxylation of proline and lysine residues during collagen biosynthesis, making it structurally essential for type II collagen formation in cartilage.
Scientific evidence: Cross-sectionally, a higher intake of both vitamin C and D was associated with less cartilage degeneration, as evidenced by an inverse relationship with cartilage T2 values (particularly for vitamin C) and with cartilage WORMS scores (for both vitamin C and D) in data from the Osteoarthritis Initiative. Antioxidants protect the body from damaging oxidation or 'oxidative stress' which may be involved in the development and progression of osteoarthritis; though evidence for the effect of these vitamins in osteoarthritis is limited, an adequate daily intake as part of a healthy balanced diet is recommended.
4.10 Vitamin D
Role in cartilage biology: Vitamin D is essential for bone and cartilage health. Vitamin D seems to reduce chronic inflammation; its anti-inflammatory actions include downregulation of NF-κB and STAT1/5-mediated signaling, with subsequent downregulation of pro-inflammatory cytokines such as TNF-α and IL-1β. Binding of vitamin D to its receptor also results in a decrease of prostaglandin and cyclooxygenase-2 production, reduction of MMP-9, and increase in anti-inflammatory IL-10 production.
Scientific evidence: The evidence for association between the vitamin D biomarker serum 25(OH)D and OA was assessed in a systematic review; for knee radiographic OA progression and cartilage loss, there was strong evidence for an association with low 25(OH)D. In data from the Osteoarthritis Initiative, taking at least 400 IU of vitamin D at least 1–3 days per week was associated with lower odds for cartilage, meniscus, and bone marrow worsening over 4 years; similarly, taking 400 IU at least 4–6 days per week was associated with lower odds of joint structure degeneration. However, evidence for a role of vitamin D supplementation in OA is unconvincing when randomized controlled trials alone are evaluated, reflecting the difference between epidemiological associations and interventional proof.
4.11 Vitamin K
Role in cartilage biology: Vitamin K is important in cartilage metabolism as an inhibitor of extracellular matrix calcification and a promoter of cell survival and proliferation.
Scientific evidence: In the US MOST study, vitamin K deficiency was associated with incident radiographic knee OA and MRI-based cartilage lesions (RR 2.39; 95% CI, 1.05–5.40) compared with no deficiency. Patients should ensure that they meet the recommended intakes for micronutrients such as vitamin K, which has a role in bone and cartilage mineralization. Direct interventional RCT evidence for vitamin K supplementation specifically in OA remains limited.
4.12 Omega-3 Fatty Acids
Proposed mechanism: Omega-3 fatty acids, found in fish oils and other foods, encourage the body to produce chemicals that help control inflammation.
Scientific evidence: The association between metabolic syndrome, type-2 diabetes, and OA risk or progression may partly explain the apparent benefit of dietary-lipid modification resulting from increased consumption of long-chain omega-3 fatty acids from oily fish or fish oil supplements. Research suggests omega-3s may help weaken the autoimmune inflammatory symptoms of rheumatoid arthritis, and evidence also supports omega-3s as treatments for arthritis pain and joint stiffness, but further research is needed to understand which work best and at what dosages. The evidence base is stronger for inflammatory arthritis (RA) than for OA-related cartilage preservation specifically.
5. Dietary and Lifestyle Factors
5.1 Body Weight Management
The most important relationship between diet and osteoarthritis is weight. A study of 760 participants with a baseline BMI >25 kg/m² from the Osteoarthritis Initiative compared those losing weight (>5% of baseline BMI over 72 months; N=380) to controls with stable weight (N=380). Weight loss was associated with a significantly slower increase in global cartilage T2 values (a measure of cartilage composition), indicating reduced cartilage degeneration over 96 months.
The combination of modest weight loss plus moderate exercise provides better overall improvements in self-reported measures of function and pain and in performance measures of mobility in older overweight and obese adults with knee OA compared with either intervention alone.
5.2 Mediterranean and Anti-Inflammatory Dietary Patterns
An umbrella review including five systematic reviews and meta-analyses found that most evidence supported the Mediterranean diet improving osteoarthritis-related outcomes, including pain, stiffness, inflammation, and biomarkers of cartilage degeneration. The Mediterranean diet, known to be health-protective, is largely plant-based, favors olive oil over animal fats, and is high in fiber, vegetables, and fruits.
Comprehensive cross-cultural studies have shown the serious health consequences of high consumption of meat, dairy, fat, and refined grains and sugar (proinflammatory) and low consumption of whole grains, vegetables, fruits, and legumes (anti-inflammatory). This dietary pattern contributes to low-grade systemic inflammation and oxidative tissue stress, placing the immune system in an overactive state — a common denominator of conditions with lifestyle components, including arthritis.
5.3 Dietary Cholesterol and Lipid Modification
A strong association between OA and raised serum cholesterol, together with clinical effects in statin users, suggests a potential benefit of reduction of cholesterol by dietary means. The association between the metabolic syndrome and cartilage degeneration has led researchers to emphasize that OA is not a purely mechanical condition but also has important metabolic determinants.
5.4 Exercise and Physical Activity
Overweight and obese OA patients should implement a weight-loss strategy incorporating exercise tailored to mobility; increasing consumption of long-chain n-3 fatty acids (oily fish or fish oil supplements) may improve pain and function in OA patients; and reducing raised blood cholesterol and increasing intake of rich vitamin K sources may benefit OA.
5.5 Nutritional Adequacy and Micronutrients
Ensuring adequate dietary intake of the micronutrients discussed above — vitamins C, D, and K, as well as zinc, copper, and manganese, which serve as cofactors in connective tissue metabolism — is supported by the literature as part of an overall strategy for cartilage health. Great interest has been applied to nutraceutical supplements, which include a heterogeneous class of molecules with great potential to reduce inflammation, oxidative stress, pain, and joint stiffness and improve cartilage formation. However, although numerous studies have detailed the benefits of nutraceutical usage in OA, inconsistent reports of results and little statistical significance in some studies have kept them from mainstream medical usage.
6. Summary of Evidence Quality
The evidence base for nutritional and natural interventions in cartilage health ranges considerably in quality. The strongest clinical trial evidence exists for glucosamine sulphate (particularly for knee OA symptom modification), chondroitin sulfate (pain and function; structural modification less clear), and Boswellia serrata extract (multiple RCTs with consistent pain and function benefits). ASU has a moderate evidence base from controlled trials. Curcumin, collagen peptides, MSM, and oral hyaluronic acid have promising but limited or early-phase evidence, much of it industry-sponsored. Vitamins C, D, and K are supported largely by epidemiological and observational data, with direct interventional RCT evidence remaining mixed or insufficient to establish supplementation recommendations beyond meeting dietary reference intakes. Omega-3 fatty acids show consistent evidence for joint-related inflammation but their specific role in slowing cartilage structural loss in OA requires further investigation. Many of these substances face challenges of bioavailability, standardization of preparations, and heterogeneity across trials.
References
Go back